Pediatric B-cell lymphoma, unclassifiable, with intermediate features between those of diffuse large B-cell lymphoma and Burkitt lymphoma: a report of two cases

Ann Lab Med. 2015 Mar;35(2):254-6. doi: 10.3343/alm.2015.35.2.254. Epub 2015 Feb 12.

Authors

Shanxiang Zhang¹, David Wilson², Magdalena Czader¹

Affiliations

¹ Department of Pathology and Laboratory Medicine, Indiana University, IN, USA.
² AmeriPath, Indianapolis, IN, USA.

No abstract available

Publication types

Case Reports

MeSH terms

Adolescent
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Burkitt Lymphoma / pathology*
Child, Preschool
Cyclophosphamide / therapeutic use
Doxorubicin / therapeutic use
Female
Gene Rearrangement
Herpesvirus 4, Human / metabolism
Humans
Immunohistochemistry
Lymphoma, B-Cell / diagnosis*
Lymphoma, B-Cell / drug therapy
Lymphoma, Large B-Cell, Diffuse / pathology*
Male
Prednisone / therapeutic use
Proto-Oncogene Proteins c-myc / genetics
Tomography, X-Ray Computed
Vincristine / therapeutic use
Viral Matrix Proteins / immunology
Viral Matrix Proteins / metabolism

Substances

EBV-associated membrane antigen, Epstein-Barr virus
MYC protein, human
Proto-Oncogene Proteins c-myc
Viral Matrix Proteins
Vincristine
Doxorubicin
Cyclophosphamide
Prednisone

Supplementary concepts

CHOP protocol